News

Expert: Reclaim Radiation for Skin Cancer


 

EXPERT ANALYSIS FROM THE ANNUAL MEETING OF THE FLORIDA SOCIETY OF DERMATOLOGY AND DERMATOLOGIC SURGERY

Photos courtesy Dr. William I. Roth

The same 78-year-old woman with squamous cell carcinomas, at five months post therapy.

The control unit is outside the radiation room, thus avoiding the need to work behind a leaded glass window. The control unit counts down duration of treatment and features an emergency stop. "I use a baby monitor to speak with patients during treatment," Dr. Roth said. "I did have one patient who yelled that her eye shields fell off. I hit the emergency button, entered the room, and put the shields back on." The unit holds the reading (pauses therapy) and then allows physicians to continue when ready.

"Radiation therapy has been a part of dermatology basically forever. We have been treating skin cancers since before I was born," Dr. Roth said. "Now that we have some more choices, this should be a part of dermatology again. We should take this back."

Dr. Roth is a consultant and researcher for Sensus, but purchased his SRT-100 at full price.

Pages

Recommended Reading

Most Cancers Not Elevated in Vasculitis
MDedge Hematology and Oncology
Vemurafenib's Efficacy in Melanoma Wanes Over Time
MDedge Hematology and Oncology
Scalp Cooling Protects Against Chemotherapy-Induced Alopecia
MDedge Hematology and Oncology
Eyeglasses May Offer Periocular AK Protection
MDedge Hematology and Oncology
FDA Warns of QT Prolongation with Ondansetron Dose
MDedge Hematology and Oncology
ASCO, SSO Back Sentinel Lymph Node Biopsy in Melanoma
MDedge Hematology and Oncology
Melanoma In Situ Diagnoses Ramping Up
MDedge Hematology and Oncology
Biochemotherapy Gets Mixed Results in High-Risk Melanoma
MDedge Hematology and Oncology
Invasive SCC Rates Doubled in Last 20 Years
MDedge Hematology and Oncology
Washington Post Blasts Proliferation of ESAs for Anemia
MDedge Hematology and Oncology